Search Results - Daniel Argolo

  • Showing 1 - 2 results of 2
Refine Results
  1. 1

    Cost-effectiveness of ribociclib for premenopausal or perimenopausal women with HR+/HER2− advanced breast cancer: a Brazilian public health care system perspective by Daniela Dornelles Rosa, Carlos Alberto da Silva Magliano, Sergio D. Simon, Gilberto Amorim, Tomás Reinert, Luciana Landeiro, Débora de Melo Gagliato, Pedro Exman, Daniel Argolo, Gisah Guilgen, Max Mano, Laura Testa, Pedro Liedke, Romualdo Barroso, Mariana Sasse, Anna Maria Buehler

    Published in Therapeutic Advances in Medical Oncology (2022-05-01)
    Get full text
    Article


  2. 2

    Cancer outcomes in patients eligible for adjuvant cyclin-dependent kinase 4 and 6 inhibitors but spared adjuvant chemotherapy by Oncotype Dx: A multicenter retrospective GBECAM 052... by Leandro Jonata de Carvalho Oliveira, Daniela Dornelles Rosa, Artur Katz, Daniele Assad-Suzuki, Daniel Argolo, Solange Moraes Sanches, Laura Testa, José Bines, Rafael Aliosha Kaliks, Debora de Melo Gagliato, Romualdo Barroso-Sousa, Tatiana Strava Corrêa, Andrea Kazumi Shimada, Carlos Henrique dos Anjos, Rudinei Linck, Thais Baccili Cury Megid, Daniel Negrini Batista, Daniel Musse Gomes, Marcelle Goldner Cesca, Débora Gaudêncio, Larissa Matos Almeida Moura, Julio Antonio Pereira de Araújo, Renata Colombo Bonadio, Zenaide Silva de Souza, Juliana Rodrigues Beal, Mario Machado Lopes, Leticia Telles Sales, Júlia Leal Franco Parisi Marlière, Max Senna Mano

    Published in Breast (2025-10-01)
    Get full text
    Article


Search Tools: